Search results for " opportunity"
Article
Finding Opportunities in Brazil
The researchers said they believed that high-quality patented medicines were a profitable opportunity.
In 2010, however, the value of prescription drugs sold to Brazil’s middle class was $8 billio…
Article
Mechanistic Modeling: Current Advantages and Future Opportunities in Biopharmaceutical Process Development
Mechanistic modeling is considered a part of smart process development, which is a collection of approaches to get better process outcomes and speed up process development.
This week, Bioproce…
Article
Mechanistic Modeling of Chromatography: Opportunities and Challenges
What is mechanistic modeling in chromatography? Explore opportunities and challenges of an approach that can help make process development become faster, more scientific, and more reliable.
Cl…
Article
Sanitization Opportunities for Protein A Resins
Click here to read more >>
Bacterial endospores present a challenge in bioproduction due to their resistance to common sanitization procedures using high concentrations of NaOH. Several protein-b…
Poster
Opportunities, Challenges, and Economic Drivers for Start-to-Finish Continuous Biomanufacturing
Continuous unit operations have been used successfully in manufacturing of several approved products with a collective revenue of $25 billion annually. Many large biopharmaceutical organizations are…
Article
Climate Change in Outsourcing
Their challenge is that the opportunity to acquire redundant facilities from global bio/pharma companies at favorable prices, which worked so well for them in Europe, is practically non-existent in No…
Article
FDA Framework Spurs Advanced Therapies
Framework of opportunities
Because the new framework provides increased opportunity for developers of regenerative medicinal products to obtain expedited reviews and greater access and collaborati…
Article
A Look Ahead at BioPharma Manufacturing and Regulation
BioPharm: Can you comment on the staff training workshops held to date with these centers and their benefit to agency reviewers?
FDA: Agency reviewers have had the opportunity to participate in …
Article
Genetic Vaccine Platforms Demonstrate Their Potential
“This issue can make repeated dosing difficult, since with additional dosing, the patient’s immune system may clear the viral vector before it has an opportunity to insert the nucleic acid into a cell…
Article
Moving PAT from Concept to Reality
We believe that public-private partnerships that enable multiple stakeholders to innovate collaboratively provide the opportunity to de-risk such advances,” he states.
“It is essential to reduce t…